Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Am Surg ; 81(12): 1244-8, 2015 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-26736162

RESUMO

This study sought to evaluate the incidence of ostomy site incisional hernias after stoma reversal at a single institution. This is a retrospective analysis from 2001 to 2011 evaluating the following demographics: age, gender, indication for stoma, urgent versus elective operation, time to closure, total follow-up time, the incidence of and reoperation for stoma incisional hernia, diabetes, postoperative wound infection, smoking status within six months of surgery, body mass index, and any immunosuppressive medications. A total of 365 patients were evaluated. The median follow-up time was 30 months. The clinical hernia rate was 19 percent. Significant risk factors for hernia development were age, diabetes, end colostomies, loop colostomies, body mass index >30, and undergoing an urgent operation. The median time to clinical hernia detection was 32 months. Sixty-four percent of patients required surgical repair of their stoma incisional hernia. A significant number of patients undergoing stoma closure developed an incisional hernia at the prior stoma site with the majority requiring definitive repair. These hernias are a late complication after stoma closure and likely why they are under-reported in the literature.


Assuntos
Colostomia/efeitos adversos , Hérnia Ventral/epidemiologia , Ileostomia/efeitos adversos , Estomia/efeitos adversos , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Criança , Feminino , Seguimentos , Hérnia Ventral/etiologia , Humanos , Incidência , Masculino , Pessoa de Meia-Idade , New York/epidemiologia , Reoperação , Estudos Retrospectivos , Adulto Jovem
2.
J Investig Med High Impact Case Rep ; 2(3): 2324709614545225, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-26425618

RESUMO

The health risks and side effects of fluoroquinolone use include the risk of tendon rupture and myasthenia gravis exacerbation, and on August 15, 2013, the Food and Drug Administration updated its warning to include the risk of permanent peripheral neuropathy. We present a case of fluoroquinolone-induced peripheral neuropathy in a patient treated for clinically diagnosed urinary tract infection with ciprofloxacin antibiotic.

SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa